CHINA Poised for More Growth

Tags: china
5 Jan 11:03pm
Posted by ZacksResearch
0 Comments
Read original blog entry

After beginning life as a pan-Asian integrated Internet company, CDC Corporation (CHINA) changed its name to chinadotcom corporation in 2000 to provide a proper identity to the company. It then changed its name to CDC Corporation in 2005 to better reflect the company's development into a larger and more diverse enterprise.

Ever since its inception as an Internet pioneer in Asia, the company has grown and evolved into a global provider of enterprise software, online games, business solutions, mobile and Internet applications.

With a strong track record in consolidation and organic growth of its software business, we believe CDC is poised for growth. With continuous focus on vertical industries and cost reduction initiatives in its software segment, CDC should develop a significant competitive advantage in 2009 and beyond.

New launches and upgrades (Yulgang 2.0 and Ross Enterprise v6.3) in its product line as well as its share repurchase plan currently in action will further help the company drive growth. As such, we maintain our Buy rating on the shares of CDC with a six-month target price of $3.50.

Priyanka Poddar contributed to this report.

Read the full analyst report on CHINA




Get real-time market insights and profitable stock recommendations from the team of analysts at Zacks Equity Research. See all today’s Analyst Blog entries on Zacks.com.

Comments

Back to top

Post comment

Back to top

Post a comment

Please login to post a comment

About

ZacksResearch

Zacks Investment Research is one of the most highly regarded firms in the investment industry. Our firm has long believed that that quantitative models (like the Zacks Rank) can predict stock prices more accurately than individual analysts. However we also recognize that models are most effective when they are employed by analysts who have deep fundamental knowledge of the company and its industry. Consequently Zacks Equity Research combines Zacks quantitative models with the insight provided by an experienced team of 50 analysts to create superior long term stock recommendations. Discover all their timely insight and recommendations daily on Zacks.com.

Recent Entries